Indomethacin for prevention of heterotopic ossification after hip arthroplasty

Acta Orthopaedica Scandinavica

Volumn 69, Issue 2, 1998, Pages 107-110

  Dorn, Ulrich ^a   Grethen, Claude ^a   Effenberger, Harald ^a   Berka, Hans ^a   Ramsauer, Thomas ^a   Drekonja, Thomas ^a  

^a St Johanns Spital   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGESTIVE SYSTEM FUNCTION DISORDER; DRUG EFFICACY; FEMALE; HETEROTOPIC OSSIFICATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; TOTAL HIP PROSTHESIS; TREATMENT PLANNING;

EID: 0031947297     PISSN: 00016470     EISSN: None     Source Type: Journal    
DOI: 10.3109/17453679809117607     Document Type: Article

References (35)

1. Ahrengart L, Lindgren U. Heterotopic bone after hip arthroplasty. Defining the patient at risk. Clin Orthop 1993; 293: 153-9.
2. Ahrengart L, Blomgren G, Törnkvist H. Short-term ibuprofen to prevent ossification after hip arthroplasty. No effects in a prospective randomized study of 47 arthrosis cases. Acta Orthop Scand 1994; 65 (2): 139-41.
3. Arcq M. Die paraartikularen Ossifikationen - eine Komplikation der Totalendoprothese des Huftgelenkes. Arch Orthop Unfall-Chir 1973; 77: 108-31.
4. Bauer R, Kerschbaumer F, Poisel S. Operative Zugangswege in Orthopadie und Traumatologie. Georg Thieme Verlag, Stuttgart 1986.
5. Brooker A F, Bowerman J W, Robinson R A, Riley L H Jr. Ectopic ossification following total hip replacement. Incidence and method of classification. J Bone Joint Surg (Am) 1973; 55 (8): 1629-32.
6. Cella J P, Salvati E A, Sculco T P. Indomethacin for the prevention of heterotopic ossification following total hip arthroplasty. Effectiveness, contraindications and adverse effects. J Arthroplasty 1988; 3 (3): 229-34.
7. Dahl H K. Kliniske observasjoner. Symposium on hip arthrosis. Blindern, Norway. Merck, Sharp and Dome 1975: 37-46.
8. DeLee J, Ferrari A, Charnley J. Ectopic bone formation following low friction arthroplasty of the hip. Clin Orthop 1976; 121: 53-9.
9. Elmstedt E, Lindholm T S, Nilsson O S, Törnkvist H. Effect of ibuprofen on heterotopic ossification after hip replacement. Acta Orthop Scand 1985; 56 (1): 25-7.
10. Errico T J, Fetto J F, Waugh T R. Heterotopic ossification. Incidence and relation to trochanteric osteotomy in 100 total hip arthroplasties. Clin Orthop 1984; 190: 138-41
11. Eyb R, Zweymüller K. Periartikulare Ossifikationen nach Implantation zemenffreier Hufttotalendoprothesen vom Typ Zweymuller Endler. Z Orthop 1985; 123 (6): 975-80.
12. Gebuhr P, Soelberg M, Orsnes T, Wilbek H. Naproxen prevention of heterotopic ossification after total hip arthroplasty. A prospective control study of 55 patients. Acta Orthop Scand 1991; 62 (3): 226-9.
13. Gebuhr P, Sletgard J, Dalsgard J, Soelberg M, Keisu K, Hanninen A, Crawford M. Heterotopic ossification after hip arthroplasty. A randomized double-blind multicenter study of tenoxicam in 147 hips. Acta Orthop Scand 1996; 67 (1): 29-32.
14. Hamblen D L. Ectopic ossification. In: Complications of total hip replacement. (Ed. Ling R S M) Churchill Living-stone, London 1984.
15. Hanslik L, Rudloff H. Der Krankheitswert paraartikularer Verknocherungen nach total-endoprothetischem Huftgelenksersatz. Arch Orthop Unfallchir 1974; 80 (2): 153-64.
16. Hierton C, Blomgren G, Lindgren U. Factors associated with heterotopic bone formation in cemented total hip prosthesis. Acta Orthop Scand 1983; 54: 698-702.
17. Hoikka V, Lindholm T S, Eskola A. Flurbiprofen inhibits helerotopic bone formation in total hip arthroplasty. Arch Orthop Trauma Surg 1990; 109 (4): 224-6.
18. Kjaersgaard-Andersen P, Schmidt S A. Indomethacin for prevention of ectopic ossification after hip arthroplasty. Acta Orthop Scand 1986; 57: 12-4.
19. Kjaersgaard-Andersen P, Ritter M A. Short-term treatment with nonsteroidal antiinflammatory medications to prevent heterotopic bone formation after total hip arthroplasty. A preliminary report. Clin Orthop 1992; 279: 157-62.
20. Kjaersgaard-Andersen P, Nafei A, Teichert G, Kristensen O, Schmidt S A, Keller J, Lucht U. Indomethacin for prevention of heterotopic ossification. A randomized controlled study in 41 hip arthroplasty. Acta Orthop Scand 1993; 64 (6): 639-42.
21. Kromann-Andersen C, Sorensen T S, Hougaard K, Zdravkovic D, Frigaard E. Ectopic bone formation following Charnley hip arthroplasties. Acta Orthop Scand 1980; 51 (4): 633-8.
22. Maloney W J, Krushell R J, Jasty M, Harris W H. Incidence of heterotopic ossification after total hip replacement: effect on the type of fixation of the femoral component. J Bone Joint Surg (Am) 1991; 73 (2): 191-3.
23. McMahon J S, Waddell J P, Morton J. Effect of short-course indomethacin on heterotopic bone formation after uncemented total hip arthroplasty. J Arthroplasty 1991; 6: 259-64.
24. Metzenroth H, Publig W, Knahr K, Zandl C, Kuchner G, Carda C. Ossifikationsprophylaxe nach Hufttotalendoprothesen mit Indomethacin und ihr Einfluss auf die Magenschleimhaut. Z Orthop 1991; 129 (2): 178-82.
25. Morrey B F, Adams R A, Cabanela M E. Comparison of hetcrotopic hone after anterolateral. transtrochanteric and posterior approaches for total hip arthroplasty. Clin Orthop 1984; 188: 160-7.
26. Nilsson O S, Bauer H C F, Brosjö O, Törnkvist H. Influence of indomethacin on induced heterotopic hone formation in rats. Clin Orthop 1986; 207: 239-46.
27. Nollen A J G, Sloof T J J H. Paraarticular ossifications after total hip replacement. Acta Orthop Scand 1973; 44 (2): 230-41.
28. Reis H J, Kusswetter W, Schellinger T. The suppression of heterotopic ossification after total hip arthroplasty. Int Orthop 1992; 16 (2): 140-5.
29. Ritter M A, Gioe T J. The effect of indomethacin on paraarticular ectopic ossification following total hip arthroplasty. Clin Orthop 1982; 167: 113-7.
30. Ritter M A, Sieber J M. Prophylactic indomethacin for the prevention of heterotopic bone formation following total hip arthroplasty. Clin Orthop 1985; 196: 217-25.
31. Schmidt S A, Kjærsgaard-Andersen P, Pedersen N W, Kristensen S S, Pedersen P, Nielsen J B. The use of indomethacin to prevent the formation of heterotopic bone after total hip replacement. A randomized, double-blind clinical trial. J Bone Joint Surg (Am) 1988; 70 (6): 834-8.
32. Søballe K, Christensen F, Kristensen S S. Ectopic bone formation after total hip arthroplasty. Clin Othop 1988; 228: 57-62.
33. Törnkvist H, Bauer F C, Nilsson O S. Influence of Indomethacin on experimental bone metabolism in rats. Clin Orthop 1985; 193: 264-70.
34. Wahlström O, Risto O, Djerf K, Hammerby S. Heterotopic bone formation prevented by diclofenac: prospective study of 100 hip arthroplasties. Acta Orthop Scand 1991; 62: 419-21.
35. Wurnig C, Eyb R, Auersperg V. Indomethacin for prevention of ectopic ossification in cementless hip arthroplasties. A prospective 1 -year study of 100 cases. Acta Orthop Scand 1992; 63 (6): 628-30.